EP0321201A3
Ribozymes
Abstract
Synthetic RNA molecules having highly specific endoribonuclease activity (hereinafter referred to as "ribozymes") are described. The ribozymes comprise a hybridizing region which is complementary in nucleotide sequence to at least part of a target RNA, and a catalytic region which is adapted to cleave the target RNA. Methods for inactivating RNA, and compositions containing ribozymes are also described.

Term
Term ended
Projected expiry passed 14 December 2008, 17.8 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| WO8804300A1 | Cites | World Intellectual Property Organization (WIPO) | XPD | Search report |
54 members in 26 offices
Priority claims25
| Document | Office | Kind | Date |
|---|---|---|---|
| 591187 | Australia | – | |
| PI591187 | Australia | A | |
| PI591187 | Australia | A | |
| 995088 | Australia | – | |
| PI995088 | Australia | A | |
| PI995088 | Australia | A | |
| 35388 | Australia | – | |
| PJ035388 | Australia | A | |
| PJ035388 | Australia | A | |
| 130488 | Australia | – | |
| PJ130488 | Australia | A | |
| PJ130488 | Australia | A | |
| 133388 | Australia | – | |
| PJ133388 | Australia | A | |
| PJ133388 | Australia | A | |
| 130488 | – | – | – |
| 133388 | – | – | – |
| 35388 | – | – | – |
| 591187 | – | – | – |
| 995088 | – | – | – |
| AU1987PI05911 | – | – | – |
| AU1988PI09950 | – | – | – |
| AU1988PJ00353 | – | – | – |
| AU1988PJ01304 | – | – | – |
| AU1988PJ01333 | – | – | – |
Members54
| Document | Office | Kind | |
|---|---|---|---|
| EP0321201A2 | European Patent Office (EPO) | A2 | |
| WO8905852A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CN1033838A | China | A | |
| AU2800789A | Australia | A | |
| ZA889352B | South Africa | B | |
| EP0321201A3This record | European Patent Office (EPO) | A3 | |
| DK143390D0 | Denmark | D0 | |
| NO902661D0 | Norway | D0 | |
| DK143390A | Denmark | A | |
| NO20000369L | Norway | L | |
| NO902661L | Norway | L | |
| KR900700603A | Republic of Korea | A | |
| HUT54407A | Hungary | A | |
| JPH03502638A | Japan | A | |
| MC2115A1 | Monaco | A1 | |
| NZ227332A | New Zealand | A | |
| AU632993B2 | Australia | B2 | |
| IN171821B | India | B | |
| BG51160A3 | Bulgaria | A3 | |
| AR243935A1 | Argentina | A1 | |
| US5254678A | United States of America | A | |
| EP0321201B1 | European Patent Office (EPO) | B1 | |
| AT115999T | Austria | T | |
| DE3852539D1 | Germany | D1 | |
| EP0640688A1 | European Patent Office (EPO) | A1 | |
| ES2065919T3 | Spain | T3 | |
| DE3852539T2 | Germany | T2 | |
| GR3015374T3 | Greece | T3 | |
| IL88683A | Israel | A | |
| HU211891A9 | Hungary | A9 | |
| US5494814A | United States of America | A | |
| US5543508A | United States of America | A | |
| US5574143A | United States of America | A | |
| US5589580A | United States of America | A | |
| KR970010758B1 | Republic of Korea | B1 | |
| US5707835A | United States of America | A | |
| US5747335A | United States of America | A | |
| US5766942A | United States of America | A | |
| SG52270A1 | Singapore | A1 | |
| US5840874A | United States of America | A | |
| RO114469B1 | Romania | B1 | |
| CA1340831C | Canada | C | |
| RU2144080C1 | Russian Federation | C1 | |
| NO20000369D0 | Norway | D0 | |
| FI104562B | Finland | B | |
| JP3046318B2 | Japan | B2 | |
| NO308610B1 | Norway | B1 | |
| US6127114A | United States of America | A | |
| NO312105B1 | Norway | B1 | |
| CN1102174C | China | C | |
| EP0321201B2 | European Patent Office (EPO) | B2 | |
| ES2065919T5 | Spain | T5 | |
| DE3852539T3 | Germany | T3 | |
| DK175956B1 | Denmark | B1 |
74 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB | PLAB | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fr: translation filed ** decision concerning oppositionOppositionET3 | ET3 | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH | APAH | EP | |
| Patent modifiedDC2A | DC2A | ES | |
| Nl: receipt of modified translations in the netherlands language after an opposition procedureOppositionNLR3 | NLR3 | EP | |
| Ep patent validated in greeceEP | EP | GR | |
| Ep patent has been republished in amended form after opposition at epoOppositionRPEO | RPEO | SE | |
| Nl: decision of oppositionOppositionNLR2 | NLR2 | EP | |
| Scope or validity of the patent modifiedAUFRECHTERHALTUNG DES PATENTES IN GEAENDERTER FORMAEN | AEN | CH | |
| Patent maintained in amended form27A | 27A | EP | |
| Designated contracting statesAK | AK | EP | |
| Patent maintained in amended formORIGINAL CODE: 0009272PUAH | PUAH | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA | STAA | EP | |
| Appeal procedure closedAppealORIGINAL CODE: EPIDOSNNOA9OAPBU | APBU | EP | |
| Appeal dossier modifiedAppealORIGINAL CODE: EPIDOS NOAPOAPAC | APAC | EP | |
| Appeal dossier modifiedAppealORIGINAL CODE: EPIDOS NOAPOAPAC | APAC | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Appeal dossier modifiedAppealORIGINAL CODE: EPIDOS NOAPOAPAC | APAC | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOS REFNOAPAE | APAE | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOS REFNOAPAE | APAE | EP | |
| Appeal dossier modifiedAppealORIGINAL CODE: EPIDOS NOAPOAPAC | APAC | EP | |
| Interlocutory decision in oppositionOppositionORIGINAL CODE: EPIDOS IDOPPLAW | PLAW | EP | |
| Change of addressCA | CA | FR | |
| Nl: modifications (of names), taken from the european patent patent bulletinNLT2 | NLT2 | EP | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Name/firm changedGENE SHEARS PTY LIMITED,SUITE 1, BUILDING 5, 105 DELHI ROAD,NORTH RYDE, NSW 2113 (AU) TRANSFER- GENE SHEARS PTY LIMITED,ADMINISTRATION BUILDING CNR BARRY DRIVE-CLUNIES ROSS STREET GPO BOX 1600,CANBERRA, ACT 2601 (AU)PFA | PFA | CH | |
| Change of addressCA | CA | FR | |
| Nl: modifications (of names), taken from the european patent patent bulletinNLT2 | NLT2 | EP | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Name/firm changedGENE SHEARS PTY LTD,154 PACIFIC HIGHWAY, LEVEL 2,ST. LEONARDS/NSW (AU) TRANSFER- GENE SHEARS PTY LIMITED,SUITE 1, BUILDING 5, 105 DELHI ROAD,NORTH RYDE, NSW 2113 (AU)PFA | PFA | CH | |
| Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF | PLBF | EP | |
| Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF | PLBF | EP | |
| Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF | PLBF | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Validation in greece3015374FG4A | FG4A | GR | |
| Fr: translation filedET | ET | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Corresponds to:REF | REF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0321201
- Publication, DOCDB
- 0321201
- Publication, EPODOC
- EP0321201
- Application
- 88311816
- Application, DOCDB
- 88311816
- Application, EPODOC
- EP19880311816
Titles3
- English
- Ribozymes
- German
- Ribozyme
- French
- Ribozymes
Classification
- CPC, 10
- C12N15/113
- A01N57/16
- A01N63/00
- A61K38/00
- A61P31/12
- C12N15/8218
- C12N2310/12
- C12N2310/121
- C12N2310/124
- A01N63/60
- IPC, 21
- C12N9 22
- A01N57 16
- A01N63 60
- A61K
- A61K31 70
- A61K31 7105
- A61K38 00
- A61K39 235
- A61K39 285
- A61P31 12
- C07H
- C07H21 02
- C12N1 20
- C12N5 02
- C12N5 10
- C12N15 00
- C12N15 09
- C12N15 113
- C12N15 52
- C12N15 82
- C12P19 34
Designated states13
- Contracting states, 13
- Austria
- Belgium
- Switzerland
- Germany
- Spain
- France
- United Kingdom
- Greece
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden